<DOC>
	<DOC>NCT03045965</DOC>
	<brief_summary>HOPPSA is a register based randomized controlled trial (R-RCT), with the objective to examine if opportunistic salpingectomy compared with no salpingectomy, at the time of hysterectomy for a benign reason - has no increased risk of complications - has no negative side effects on ovarian function and subsequent cardiovascular disease or incidence of fractures - implies reduced risk of subsequent ovarian cancer Randomization and follow-up will be conducted within national registers.</brief_summary>
	<brief_title>Hysterectomy and OPPortunistic SAlpingectomy</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Planned hysterectomy for a benign reason Age &lt; 55 years at randomization Willing to be randomized Vaginal route may be included if the surgeon is confident with performing vaginal salpingectomy. Previous bilateral oophorectomy and/or salpingectomy Planned oophorectomy and/or salpingectomy (for reasons such as already diagnosed adnexal tumor, known carrier of the breast cancer susceptibility gene (BRCA) 1/2 mutation or Lynch syndrome (hereditary nonpolyposis colorectal cancer)) Nonunderstanding of the oral or written study information</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Salpingectomy</keyword>
	<keyword>Hysterectomy</keyword>
	<keyword>Ovarian cancer</keyword>
</DOC>